EyeQue
- Industry
- Healthcare Services
- Founded Year
- 2015
- Headquarters
- Newark, California, USA
- Employee Count
- 50
Key People
- Dr. John Serri - Co-founder and CEO
- Tibor Laczay - Co-founder and CTO
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The founding team comprises experienced professionals with over a decade in their respective fields.
Dr. John Serri and Tibor Laczay bring significant expertise, contributing to the company's innovative approach in vision testing solutions.
- Clinical Need
-
Aspect: Strong
Summary: There is a substantial demand for accessible and affordable vision testing solutions.
With increasing prevalence of eye disorders and a growing aging population, EyeQue's solutions meet a critical need for convenient eye care.
- Competition
-
Aspect: Somewhat crowded
Summary: The market has several players offering vision testing solutions.
While EyeQue offers innovative products, it faces competition from established companies in the ophthalmic devices market.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing accurate and user-friendly at-home vision testing devices presents moderate technical challenges.
Balancing technical precision with ease of use requires careful design and testing to meet consumer expectations.
- Patent
-
Aspect: Strong
Summary: The company holds strong patents protecting its technology.
EyeQue's patents safeguard its innovations, preventing easy replication by competitors and supporting market positioning.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding to support its operations and growth.
With substantial investment, EyeQue is well-positioned to scale its operations and enhance its product offerings.
- Regulatory
-
Aspect: 510k/PMA
Summary: The company has obtained necessary regulatory approvals for its devices.
Achieving FDA 510(k) clearance demonstrates the safety and efficacy of EyeQue's products, building consumer trust.
Opportunity Rollup
- Odds of Success
- 3.8
- Peak Market Share
- 5.45
- Segment CAGR
- 4.3%
- Market Segment
- Ophthalmic Devices
- Market Sub Segment
- Vision Care Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.27 |
| 2 | 0.82 |
| 3 | 1.91 |
| 4 | 3.82 |
| 5 | 5.45 |
Key Takeaway
EyeQue's innovative at-home vision testing solutions position it well in a growing market, supported by strong leadership and financial backing.